Xizang Haisco Pharmaceutical Group Co Ltd (002653) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.009x

Based on the latest financial reports, Xizang Haisco Pharmaceutical Group Co Ltd (002653) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥39.68 Million ≈ $5.81 Million USD) by net assets (CN¥4.23 Billion ≈ $618.26 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Xizang Haisco Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Xizang Haisco Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Xizang Haisco Pharmaceutical Group Co Lt balance sheet liabilities for a breakdown of total debt and financial obligations.

Xizang Haisco Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Xizang Haisco Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Autoliv Inc ST:ALIV-SDB	0.221x
Sinotruk (Hong Kong) Limited F:4SK	0.030x
Acuity Brands Inc NYSE:AYI	0.050x
Cognex Corporation NASDAQ:CGNX	0.050x
Generac Holdings Inc NYSE:GNRC	0.045x
Sibanye Gold Ltd ADR NYSE:SBSW	0.297x
CATHAY PAC.AIRW.HD-20ADR5 F:CTYA	N/A
Medibank Private Ltd AU:MPL	-0.085x

Annual Cash Flow Conversion Efficiency for Xizang Haisco Pharmaceutical Group Co Ltd (2008–2024)

The table below shows the annual cash flow conversion efficiency of Xizang Haisco Pharmaceutical Group Co Ltd from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see Xizang Haisco Pharmaceutical Group Co Lt (002653) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥4.20 Billion ≈ $614.92 Million	CN¥442.05 Million ≈ $64.69 Million	0.105x	-2.42%
2023-12-31	CN¥4.17 Billion ≈ $610.28 Million	CN¥449.58 Million ≈ $65.79 Million	0.108x	+257.26%
2022-12-31	CN¥3.13 Billion ≈ $458.52 Million	CN¥94.55 Million ≈ $13.84 Million	0.030x	+146.11%
2021-12-31	CN¥2.92 Billion ≈ $427.32 Million	CN¥35.80 Million ≈ $5.24 Million	0.012x	-83.03%
2020-12-31	CN¥2.85 Billion ≈ $417.74 Million	CN¥206.21 Million ≈ $30.17 Million	0.072x	-77.54%
2019-12-31	CN¥2.38 Billion ≈ $347.78 Million	CN¥764.26 Million ≈ $111.84 Million	0.322x	+35.70%
2018-12-31	CN¥1.99 Billion ≈ $291.83 Million	CN¥472.61 Million ≈ $69.16 Million	0.237x	+19.17%
2017-12-31	CN¥1.97 Billion ≈ $288.32 Million	CN¥391.81 Million ≈ $57.33 Million	0.199x	+5.68%
2016-12-31	CN¥2.26 Billion ≈ $331.38 Million	CN¥426.11 Million ≈ $62.35 Million	0.188x	-8.40%
2015-12-31	CN¥2.16 Billion ≈ $315.58 Million	CN¥443.03 Million ≈ $64.83 Million	0.205x	-13.86%
2014-12-31	CN¥2.11 Billion ≈ $308.37 Million	CN¥502.57 Million ≈ $73.54 Million	0.238x	-19.15%
2013-12-31	CN¥1.93 Billion ≈ $281.97 Million	CN¥568.41 Million ≈ $83.18 Million	0.295x	+8.40%
2012-12-31	CN¥1.71 Billion ≈ $249.91 Million	CN¥464.75 Million ≈ $68.01 Million	0.272x	-19.89%
2011-12-31	CN¥767.76 Million ≈ $112.35 Million	CN¥260.79 Million ≈ $38.16 Million	0.340x	-58.11%
2010-12-31	CN¥453.09 Million ≈ $66.30 Million	CN¥367.38 Million ≈ $53.76 Million	0.811x	-70.23%
2009-12-31	CN¥135.17 Million ≈ $19.78 Million	CN¥368.21 Million ≈ $53.88 Million	2.724x	+519.97%
2008-12-31	CN¥214.95 Million ≈ $31.45 Million	CN¥94.45 Million ≈ $13.82 Million	0.439x	--

About Xizang Haisco Pharmaceutical Group Co Ltd

SHE:002653 China Biotechnology

Market Cap

$8.97 Billion

CN¥61.33 Billion CNY

Market Cap Rank

#2440 Global

#310 in China

Share Price

CN¥54.76

Change (1 day)

-5.03%

52-Week Range

CN¥40.99 - CN¥61.47

All Time High

CN¥61.47